Ionis Pharmaceuticals Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
This webcast presentation is for Bank of America clients only. If you are a member or a representative of the media or press, please disconnect now.
Good day, everybody. My name is Jason Gerberry; I am one of the biotech analysts at Bank of America. I am pleased to be introducing our next company presenter, Ionis and CFO Beth Hougen. So, Beth, first off, thanks for joining us at the conference once again virtually.
Thank you for having us. We are glad to be here. Happy to be here.
Questions & Answers
Great, great. Well look, the Company has been a leader in the RNAi space -- or the RNA interfering space for quite some time. And maybe -- you had a lot of interesting success with Spinraza, and I'm curious if you can talk a little bit about what you see as some of the next key inflection points in the story,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
